Koo Hyeon Ahn

Title: Koo Hyeon Ahn: Innovator in Vascular Leakage Blockers

Introduction

Koo Hyeon Ahn is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of vascular leakage blockers. With a total of 2 patents to his name, Ahn's work is characterized by innovation and a focus on high-quality drug substances.

Latest Patents

Ahn's latest patents include a crystalline form of a vascular leakage blocker compound. This invention relates to a crystalline form of (E)-methyl 6-((3S,8S,9S,10R,13S,14S,17R)-3-(((5S,6R)-5-acetoxy-6-(acetoxytnethyl)-5,6-dihydro-2H-pyran-2-yl)oxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-17-yl)hept-5-enoate and a blood vessel leak blocker comprising the same. This novel crystalline form boasts high purity, excellent stability, and pharmaceutical reliability, making it advantageous for producing high-quality drug substances. Another significant patent is a preparation method for vascular leakage blockers with a high yield. This method is more productive and economical than conventional methods, utilizing an intermediate that effectively removes impurities generated during the reaction.

Career Highlights

Throughout his career, Koo Hyeon Ahn has worked with reputable organizations, including Curacle Co., Ltd. and Yonsei University. His experience in these institutions has allowed him to refine his skills and contribute to advancements in pharmaceutical research.

Collaborations

Ahn has collaborated with notable colleagues such as Myung-Hwa Kim and Chul Su Baek. These partnerships have further enhanced his research and development efforts in the field of vascular leakage blockers.

Conclusion

Koo Hyeon Ahn is a distinguished inventor whose work in vascular leakage blockers has the potential to significantly impact the pharmaceutical industry. His innovative patents and collaborations reflect his commitment to advancing medical science.